Science news

NMPA Approves the NDA for CARsgen's BCMA CAR-T Therapy Zevorcabtagene Autoleucel for Relapsed or Refractory Multiple Myeloma

SHANGHAI, March 1, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment...

CathSOLVER™ simplifies MicroCatheter Design Development

Roth Technologies, LLC announces the release of the CathSOLVER™ function add-in for the CathCAD® Standard software with a general availability date of March 1,...

Telemedicine Market Projected to Soar to US$ 317.59 Billion by 2030, Driven by High-tech Healthcare Services and Innovation

DUBLIN, Feb. 29, 2024 /PRNewswire/ -- The "Telemedicine Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has...

Sunmed™ | Your CBD StoreⓇ Backs Proposed Hemp Legislation in Georgia

Bipartisan GA Senate Bill 437 Slated to Promote Safe and Informed Consumption of Naturally-Derived Hemp Products, Set to Remove "Bad Actors" From Marketplace PALMETTO, Fla.,...

NZero Announces Partnership with World Wide Technology to Support Carbon Measurement Offerings

Data center partners of World Wide Technology will now have access to NZero emissions reports to inform decarbonization strategies and reach regulatory compliance RENO, Nev., Feb....

BioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congress

STOCKHOLM, Feb. 29, 2024 /PRNewswire/ -- BioArctic AB (publ) (STO: BIOA-B) today announced that the company and its partner Eisai will present new data on...

Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock

SAN DIEGO, Feb. 28, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...

CROWN SIGNS RENEWABLE ENERGY DEAL SIGNIFICANTLY EXPANDING COVERAGE OF ITS ELECTRICITY CONSUMPTION IN EUROPE

Renewable energy (RE) adoption drives Crown's Twentyby30™ targets forward; new Virtual Power Purchase Agreement (VPPA) shows continued commitment to sustainability TAMPA, Fla., Feb. 28, 2024...

Arkstone Expands the Fight Against Antimicrobial Resistance to New Fronts with the Launch of GlobalGuidance

BOCA RATON, Fla., Feb. 28, 2024 /PRNewswire/ -- Arkstone Medical Solutions, the leading force in laboratory infectious disease reporting and proactive antimicrobial stewardship, is...

Latest articles